Insuline Medical Ltd

TA:INSL Israel Other
Market Cap
$7.24K
ILA2.70 Million ILA
Market Cap Rank
#45494 Global
#449 in Israel
Share Price
ILA270.00
Change (1 day)
-11.48%
52-Week Range
ILA121.00 - ILA357.00
All Time High
ILA730501.20
About

Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel.

Insuline Medical Ltd (INSL) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2017: 32.143x

Based on the latest financial reports, Insuline Medical Ltd (INSL) has a cash flow conversion efficiency ratio of 32.143x as of December 2017.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-2.02 Million) by net assets (ILA-63.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Insuline Medical Ltd - Cash Flow Conversion Efficiency Trend (2013–2017)

This chart illustrates how Insuline Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Insuline Medical Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Insuline Medical Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Insuline Medical Ltd (2013–2017)

The table below shows the annual cash flow conversion efficiency of Insuline Medical Ltd from 2013 to 2017.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2017-12-31 ILA-63.00K ILA-7.68 Million 121.921x +1705.51%
2016-12-31 ILA-1.48 Million ILA-9.99 Million 6.753x +105.85%
2015-12-31 ILA178.00K ILA-20.56 Million -115.511x -1359.47%
2014-12-31 ILA5.09 Million ILA-40.31 Million -7.915x -180.47%
2013-12-31 ILA-2.26 Million ILA-22.23 Million 9.835x --